Jane Street
SPHS

Jane Street’s Sophiris Bio, Inc. SPHS Stock Holding History

Jane Street’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,707
Closed -$10K – 6222
2019
Q2 		$10K Buy
+11,707
New +$10.3K ﹤0.01% 5040
2016
Q3 		– Sell
-27,176
Closed -$58K – 4958
2016
Q2 		$58K Buy
+27,176
New +$37.5K ﹤0.01% 3948

Other funds holding SPHS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Jane Street's SPHS Position: Q3 2019 in Review

Jane Street sold out of Sophiris Bio, Inc. (SPHS) in Q3 2019, closing a stake of 11,707 shares — an estimated $10K sold.

Jane Street first reported a position in SPHS in Q2 2016 and held it in 2 quarters. The position peaked at $58K in Q2 2016. 25 funds tracked by Wall St. Rank hold SPHS as of Q3 2019.

  • Jane Street reported no remaining Sophiris Bio, Inc. position as of Q3 2019 after selling out during the quarter.
  • Jane Street sold 11,707 Sophiris Bio, Inc. shares in Q3 2019, an estimated $10K.
  • Jane Street first reported a position in Sophiris Bio, Inc. in Q2 2016 and held it in 2 quarters.
  • Jane Street's Sophiris Bio, Inc. position peaked at $58K in Q2 2016.
  • 25 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.